CARDIOVASCULAR DISEASE IN RENAL TRANSPLANT RECIPIENTS
Authors:
- 19 May 2010
- journal article
- review article
- Published by Wiley in Journal of Renal Care
- Vol. 36 (s1) , 136-145
Abstract
SUMMARY: Renal transplant recipients have a markedly increased risk of premature cardiovascular disease (CVD) compared with the general population, although considerably lower than that of patients receiving maintenance haemodialysis. CVD in transplant recipients is poorly characterised and differs from the nonrenal population, with a much higher proportion of fatal to nonfatal cardiac events. In addition to traditional ischaemic heart disease risk factors such as age, gender, diabetes and smoking, there are additional factors to consider in this population such as the importance of hypertension, left ventricular hypertrophy and uraemic cardiomyopathy. There are factors specific to transplantation such immunosuppressive therapies and graft dysfunction which contribute to this altered risk profile. However, understanding and treatment is limited by the absence of large randomised intervention trials addressing risk factor modification, with the exception of the ALERT study. The approach to managing these patients should begin early and be multifactorial in nature.Keywords
This publication has 46 references indexed in Scilit:
- Revascularization versus Medical Therapy for Renal-Artery StenosisNew England Journal of Medicine, 2009
- Candesartan improves blood pressure control and reduces proteinuria in renal transplant recipients: results from SECRETNephrology Dialysis Transplantation, 2009
- Determinants of Left Ventricular Mass and Hypertrophy in Hemodialysis Patients Assessed by Cardiac Magnetic Resonance ImagingClinical Journal of the American Society of Nephrology, 2009
- Rosuvastatin and Cardiovascular Events in Patients Undergoing HemodialysisNew England Journal of Medicine, 2009
- Impact of Acute Rejection and New-Onset Diabetes on Long-Term Transplant Graft and Patient SurvivalClinical Journal of the American Society of Nephrology, 2008
- Minimizing Immunosuppression, an Alternative Approach to Reducing Side EffectsClinical Journal of the American Society of Nephrology, 2008
- Rosuvastatin in Older Patients with Systolic Heart FailureNew England Journal of Medicine, 2007
- Glucocorticoids and Cardiovascular DiseaseEuropean Journal of Endocrinology, 2007
- Risk Factors for Reaching Renal Endpoints in the Assessment of Lescol in Renal Transplantation (ALERT) TrialTransplantation, 2005
- Comparison of Mortality in All Patients on Dialysis, Patients on Dialysis Awaiting Transplantation, and Recipients of a First Cadaveric TransplantNew England Journal of Medicine, 1999